Reslizumab used in bronchial asthma is a monoclonal antibody against
Mepolizumab & Reslizumab are monoclonal antibodies against IL-5 used in bronchial asthma, which act by inhibiting recruitment of eosinophils.
IL-2
IL-3
IL-4
IL-5